215 related articles for article (PubMed ID: 18284620)
1. Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders.
Kunishima S; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2008 Jun; 80(6):540-4. PubMed ID: 18284620
[TBL] [Abstract][Full Text] [Related]
2. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness.
Kunishima S; Matsushita T; Shiratsuchi M; Ikuta T; Nishimura J; Hamaguchi M; Naoe T; Saito H
Eur J Haematol; 2005 Jan; 74(1):1-5. PubMed ID: 15613099
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
[TBL] [Abstract][Full Text] [Related]
4. Identification of three in-frame deletion mutations in MYH9 disorders suggesting an important hot spot for small rearrangements in MYH9 exon 24.
Miyazaki K; Kunishima S; Fujii W; Higashihara M
Eur J Haematol; 2009 Sep; 83(3):230-4. PubMed ID: 19459928
[TBL] [Abstract][Full Text] [Related]
5. Identification of the first in cis mutations in MYH9 disorder.
Miyajima Y; Kunishima S
Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
[TBL] [Abstract][Full Text] [Related]
6. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
[TBL] [Abstract][Full Text] [Related]
7. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene.
De Rocco D; Pujol-Moix N; Pecci A; Faletra F; Bozzi V; Balduini CL; Savoia A
Eur J Med Genet; 2009; 52(4):191-4. PubMed ID: 19450438
[TBL] [Abstract][Full Text] [Related]
8. First description of somatic mosaicism in MYH9 disorders.
Kunishima S; Matsushita T; Yoshihara T; Nakase Y; Yokoi K; Hamaguchi M; Saito H
Br J Haematol; 2005 Feb; 128(3):360-5. PubMed ID: 15667538
[TBL] [Abstract][Full Text] [Related]
9. Advances in the understanding of MYH9 disorders.
Kunishima S; Saito H
Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
[TBL] [Abstract][Full Text] [Related]
10. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
11. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
12. High-resolution melting analysis for detection of MYH9 mutations.
Provaznikova D; Kumstyrova T; Kotlin R; Salaj P; Matoska V; Hrachovinova I; Rittich S
Platelets; 2008 Sep; 19(6):471-5. PubMed ID: 18925516
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly].
Kimura N; Matsumoto M; Matsumoto K; Asai N; Kunishima S
Rinsho Ketsueki; 2008 Dec; 49(12):1614-8. PubMed ID: 19110523
[TBL] [Abstract][Full Text] [Related]
14. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family.
Ma ES; Wong CL; Shek TW; Hui SP
Haematologica; 2006 Jul; 91(7):1002-3. PubMed ID: 16818291
[TBL] [Abstract][Full Text] [Related]
15. [May-Hegglin anomaly--from genome research to clinical laboratory].
Kunishima S
Rinsho Byori; 2003 Sep; 51(9):898-904. PubMed ID: 14560660
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and gene analyses of six patients with MYH9-related disease].
Sun XH; Wang ZY; Cao LJ; Su J; Jiang MH; Wang GF; Yu ZQ; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):552-5. PubMed ID: 22967416
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of MYH9 mRNA at leukocyte inclusion bodies in MYH9 disorders.
Kunishima S; Hirano K; Hamaguchi M; Saito H
Eur J Haematol; 2008 Oct; 81(4):325-6. PubMed ID: 18616507
[No Abstract] [Full Text] [Related]
19. MYH9-related platelet disorders.
Althaus K; Greinacher A
Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]